Magnetic Resonance Study of Liver in Chemotherapy
NCT00578838 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2016-05-09
Summary
The purpose of this study is to see whether magnetic resonance (MR) techniques can detect changes caused by chemotherapy in the livers of patients who have been treated for colorectal cancer. Some patients who undergo chemotherapy for colorectal cancer may experience side-effects in their livers. These side effects may influence further treatment options. If this study finds that MR techniques detect changes in the liver due to chemotherapy, then MR methods may eventually be used to help patients and physicians plan further treatment.
Conditions
Interventions
- OTHER
-
Magnetic Resonance
Patients each will undergo 4 MR examinations as part of this research study.
- OTHER
-
Magnetic Resonance
You will have two MR exams on two different days. There will be no injection of contrast material. An MR exam requires about 1 hour. The second MR exam will take place 2-3 weeks after the first one. This second MR exam will take about 1 hour and will look at whether the results from the MR exams are reliable and repeatable.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Kristen Zakian, PhD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
Countries
- United States
Study Locations
More Related Trials
-
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer
NCT00975897 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
NCT06637462 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver
NCT00035919 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung
NCT00557102 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
NCT00559676 ·Status: COMPLETED ·Phase: PHASE4
-
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
NCT01807117 ·Status: COMPLETED ·Phase: NA
-
S9923 R115777 in Treating Patients With Advanced Colorectal Cancer
NCT00005833 ·Status: COMPLETED ·Phase: PHASE2
-
Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases
NCT06356584 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy
NCT00713128 ·Status: COMPLETED
-
The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment
NCT03401957 ·Status: UNKNOWN
-
NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
NCT00856375 ·Status: COMPLETED ·Phase: PHASE2
-
NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b)
NCT00598975 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00002933 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Therapy in Combination with Stereotactic Radiotherapy in Patients with Metastatic Colorectal Cancer Up to 10 Metastatic Sites
NCT05375708 ·Status: SUSPENDED ·Phase: PHASE2
-
SLN in Colon Cancer Using a Multimodal Tracer
NCT02850783 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer
NCT01285102 ·Status: TERMINATED ·Phase: PHASE1
-
Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer
NCT03380689 ·Status: WITHDRAWN ·Phase: PHASE1
-
Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer
NCT01198535 ·Status: TERMINATED ·Phase: PHASE1
-
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
NCT00250029 ·Status: COMPLETED ·Phase: NA
-
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
NCT03693807 ·Status: COMPLETED ·Phase: PHASE2
-
Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer
NCT03592641 ·Status: TERMINATED ·Phase: PHASE2
-
Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00258232 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
NCT00588900 ·Status: TERMINATED ·Phase: PHASE2
-
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
NCT02861300 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of SC-007 in Subjects With Advanced Cancer
NCT03253185 ·Status: TERMINATED ·Phase: PHASE1